PTGS2 and lung carcinoma: Among these, the prostaglandin synthase COX2, responsible for the synthesis of the immunosuppressive molecule prostaglandin E2 (PGE2), was identified as a major driver of immune evasion and resistance to immunotherapy in both mouse and human lung cancer.